(AOF) – Implanet announced a turnover down 20% in the fourth quarter, to 1.64 million euros, and an annual turnover for 2023 down 10% to 7.44 million euros. euros. The medtech specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment affirms that its cash flow of 0.25 million euros allows it to be financed until February 2024.
“Our annual turnover will have been impacted by the slowdown in our international activity” declares general manager Ludovic Lastennet. “2024 should be marked by the acceleration of the marketing of products resulting from the commercial partnership concluded with Sanyou Medical in June 2022” and by “the commercial launch of our Jazz range in China” “opening up a new territory for us with significant growth potential “.
A fundraising campaign will be launched on January 17, he adds, “to ensure the commercial development of our solutions and the financing of our cash flow needs for the next 12 months.” He specifies that Sanyou Medical has already committed 5 million euros
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
